We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
To date, multiple COVID-19 vaccines have received full registration or authorizations for emergency use and many countries have initiated vaccination campaigns. Through publication of results of Phase 1 and 3 clinical trials and of real-world effectiveness evaluation in a few countries, many of the scientific questions raised in 2020 have found responses, confirming the hopes that COVID-19 large-scale vaccination will allow the world to bring the pandemic under control.
Dr Marie-Paule Kieny is Director of Research at Inserm (Paris, France), in charge of the Priority Research Program on Antibiotic Resistance initiated by France in 2019 as part of the Investment Program for the Future. She also represents France on the Management Board of the Joint Programming Initiative on Antimicrobial Resistance, JPIAMR.
Between March 24 and July 10, 2020, she was a member of the Research and Expertise Analysis Committee (CARE), set up by President Macron, to advise the government on treatments, vaccines and tests against COVID-19. Since June 2020, she chairs the French Scientific Committee on COVID-19 vaccine.
Besides her responsibilities in France, Marie-Paule Kieny is Chair of the Board of the Drugs for Neglected Diseases Initiative (DNDi, Switzerland) and of the Medicines Patent Pool Foundation (MPPF, Switzerland). She is Vice-Chair of the Board of the Global Antibiotic Research and Development Partnership (GARDP, Switzerland), member of the Board of Directors of the Human Vaccine Project (HVP, USA), of Fondation Mérieux France) and of the Solthis association (France). She is an independent non-executive Director of bioMérieux (France). She participates in the scientific councils of several organizations active in the field of health.
Until June 2017, Dr Kieny served as Assistant Director-General for Health Systems and Innovation at the World Health Organization. Her leadership at WHO included coordinating WHO's R&D efforts during the Ebola epidemic in West Africa from 2014 to 2016 and she conceptualized the WHO R&D Blueprint, a global preparedness plan for emerging disease outbreaks. Prior to joining WHO, Marie-Paule Kieny held leading research positions in the public and private sectors in France.
Inscríbete
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.